Many growth factors are known to bind and activate either receptors possessing an intrinsic protein-tyrosine kinase activity (Yarden et al., 1986) , or those that transmit signals to the cytoplasm through the interaction with heterotrimeric GTP-binding proteins (G proteins) . The latter are collectively known as G protein-coupled receptors (GPCRs) and comprise the largest group of cell surface receptors. With more than 1000 members, they represent more than 1% of the *100 000 proteins encoded by the human genome. The best known family of GPCRs exhibit a common structural motif consisting of seven membrane-spanning regions (Dohlman et al., 1987) (Figure 1 ). These receptors can be activated by a diverse array of external stimuli, including growth factors, vasoactive polypeptides, chemoattractants, neurotransmitters, hormones, phospholipids, photons, odorants, and taste ligands. Activation of GPCRs by these agents elicits a profound change in the transmembrane a helices, thus aecting the conformation of intracellular loops uncovering previously masked G protein binding sites (Altenbach et al., 1996; Bourne, 1997; Wess, 1997) . This causes the exchange of GDP for GTP bound to the G protein a subunit, and a conformational change in three¯exible`switch regions' of Ga, activating Ga and causing its dissociation from the bg heterodimers Sondek et al., 1994 Sondek et al., , 1996 . In turn, GTP-bound G protein a subunits or bg complexes initiate intracellular signaling responses by acting on eector molecules such as adenylyl cyclases, phosphodiesterases, phospholipases, or regulating the activity of ion channels, ion transporters, and a growing number of kinases. To date, 16 distinct mammalian G protein a subunits have been identi®ed, and divided into four families based upon sequence similarity: a s , a i , a q , and a 12 (Wilkie et al., 1992) . In addition, 11-G protein g subunits and ®ve G protein b subunits have been cloned so far. Taken together, it is becoming increasingly clear that GPCRs represent one of the most diverse signal transduction systems in eukaryotic cells. The biochemical and biological consequences of this diversity in subunit composition have just begun to be appreciated. In this review, we will describe the role of GPCRs in normal and aberrant cell growth and will then focus on recent eorts aimed to elucidate their downstream intracellular signaling pathways controlling cell proliferation.
G protein-coupled receptors and cell proliferation
The use of Pertussis toxin (Ptx) , that catalyses the ADP-ribosylation of G protein a subunits of the a i family (Ui and Katada, 1990 ) thereby preventing their interaction with receptors, provided the ®rst clue that a number of mitogens act on this family of cell surface receptors. For example, Pouyssegur and colleagues noted that DNA-synthesis in CHO cells in response to thrombin was blocked by Ptx treatment, whereas the proliferative response to PDGF was Ptx-insensitive (Chambard et al., 1987; Pouyssegur et al., 1988) . A similar approach led to the discovery that one of the most potent mitogens present in serum, lysophosphatidic acid (LPA), a simple naturally occurring phospholipid, was also acting on the G protein-linked class of receptors (van Corven et al., 1989) . Many other Ptx sensitive mitogens were subsequently identi®ed (see for a review). However, biochemical studies provided evidence that many mitogens also acted on GPCRs, albeit their biological eects were mediated by Ptx-insensitive G proteins and therefore were resistant to Ptx treatment. These included thrombin acting on smooth muscle cells, bombesin on Swiss 3T3 cells and bronchial epithelium, vasopressin, bradykinin and endothelin on Swiss 3T3 cells, endothelin on human mesangial cells, substance K on human skin ®broblasts, acetylcholine receptor agonists on embryonic astrocytes, angiotensin on smooth muscle cells, and many others (see Moolenaar, 1991) . Thus, it became clear that many ligands acting via GPCRs could elicit a mitogenic response in a variety of cell types (reviewed in Rozengurt, 1986; and that these receptors can transduce proliferative signals when acting on Ptx sensitive or insensitive heterotrimeric G proteins. Furthermore, recent gene knock-out studies indicated that certain GPCRs are essential for cell growth under physiological conditions (Nagata et al., 1996) .
Oncogenic potential of G protein-coupled receptors
Constitutive activation of receptor-protein tyrosine kinases, either by structural alteration of the receptor itself or by deregulated presentation of the ligand, can induce mouse ®broblasts to acquire a fully transformed phenotype (Aaronson and Tronick, 1985; Kraus et al., 1988; Tronick and Aaronson, 1988) . Thus, it has been suggested that unrestricted activation of proliferative pathways contribute to the malignant state. Discovery of the mas oncogene (Young et al., 1986) provided the ®rst link between cellular transformation and GPCRs. The mas oncogene, which encodes a putative GPCR, was initially cloned using standard transfection assays by virtue of its ability to induce tumors in mice (Young et al., 1986) . The natural agonist for the mas oncogene product is still unknown, but is likely to be a serum component. Similarly, serotonin 1C receptors were shown to harbor transforming potential when ectopically expressed in NIH3T3 cells and activated by the serotonin present in the culture medium (Julius et al., 1989) . Using a more de®ned experimental system, muscarinic m1, m3, and m5 receptors were shown to transform NIH3T3 cells in a strictly agonist-dependent manner (Gutkind et al., 1991) . As the natural agonist for these receptors, the neurotransmitter acetylcholine, is not present in serum, it was possible to correlate biochemical responses with the biological eects elicited by an exogenously added cholinergic agonist. In addition, this approach established that while G q coupled receptors, m1, m3, and m5, were highly transforming, G i coupled receptors, m2 and m4, where without focus-forming activity, under those experimental conditions. Together, these ®ndings demonstrated that certain GPCRs could behave as potent agonist-dependent oncogenes, and raised the possibility that activating mutations in GPCRs may render them transforming. Indeed, this was subsequently shown for the a 1b G protein-linked receptor to noradrenaline (Allen et al., 1991) . In this case, speci®c point mutations in the C-terminal juxtamembrane region of the third intracellular loop of the a 1b receptor relieved the requirement of ligand activation for its transforming ability. Furthermore, the recent identi®cation of constitutively activating mutations in TSH receptors in 30% of thyroid adenomas (Parma et al., 1993) provided now a direct link between this class of receptors and human cancer. Similarly, mutationally activated LH receptors have been identi®ed in a form of familial male precocious puberty that results from hyperplastic growth of Leydig cells (Shenker et al., 1993) .
Even more prevalent than activating mutations, paracrine and autocrine stimulation of multiple GPCRs for neuropeptides and prostaglandins has been implicated in a number of human neoplasias. Particularly, bombesin, gastrin-releasing peptide (GRP), neuromedin B, bradykinin, cholecystokinin (CCK), galanin, neurotensin and vasopressin have been implicated in human small cell lung cancer (SCLC) (Cuttitta et al., 1985; Moody and Cuttitta, 1993; Schuller, 1991a,b; Sethi et al., 1992) . Many of these neuropeptides are secreted by tumor-derived cells or by the solid tumor, suggesting an autocrine or paracrine mechanism of action (Sethi and Rozengurt, 1991) . Similarly, neuropeptide receptors and their agonists have been implicated in colon adenomas and carcinomas (Hoosein et al., 1988) , and gastric hyperplasia and cancer (Tahara, 1990) . Interestingly, antibodies against these peptides or receptor antagonists have been shown to be eective in in vitro and in vivo models for SCLC, further supporting a potential causative role for GPCRs in this disease, thus providing an opportunity for novel treatment modalities Sethi et al., 1992; Thomas et al., 1992a) .
Sequences encoding functional GPCRs have also been found in the genome of a number of DNA viruses, including human cytomegalovirus (HCMV) (Bankier et al., 1991; Chee et al., 1990) , herpes virus saimiri (HVS) (Nicholas et al., 1992 ) and Kaposi's sarcoma associated herpesvirus (KSHV) (Arvanitakis et al., 1997) . The HCMV, which infects leukocytes, ®broblasts and epithelial cells, contains in its genome three predicted open reading frames, UL27, UL28, and UL33, encoding typical GPCRs, which are believed to represent functional chemokine receptors (Ahuja and Murphy, 1993; Neote et al., 1993) . Although their function in the viral life cycle is still unclear, they are believed to help elude natural host defenses through molecular mimicry of proteins normally involved in host defense mechanisms (Ahuja and Murphy, 1993) . The HVS causes fatal lymphoproliferative diseases, including leukemias and lymphomas, in several non-human primates (Nicholas et al., 1992) . The protein product of one of its genes, ECRF3, behaves as a functional chemokine receptor, with a ligand speci®city identical to that of the IL8 receptor (Nicholas et al., 1992) . Furthermore, the HVS encoded GPCR responds biochemically to IL8, suggesting a role for chemokines in the molecular pathogenesis of viral infection. Interestingly, the KSHV-encoded GPCR is also highly related to the chemokine receptor family, and has been recently shown to behave as a constitutively active G q -coupled receptor and, as predicted, to be sucient to subvert normal growth control when expressed in cultured ®broblasts (Arvanitakis et al., 1997) . In addition, recent evidence has indicated that the KSHV-GPCR can eectively activate signaling pathways typical of transforming receptors, and play an unsuspected role in angiogenesis (Bais et al., in press ).
Consistent with a role for GPCRs in normal and aberrant cell growth, constitutively active mutants of Ga i , Ga q , Ga 0 , Ga 12 and Ga 13 were also shown to behave as transforming genes in a variety of cell types, and mutationally activated Ga proteins were identi®ed in several disease states (reviewed in . For example, mutationally activated Ga s , referred to as the gsp oncogene (Landis et al., 1989) , results in hyperplasia of endocrine cells, and are present in human thyroid and pituitary tumors (reviewed in Dhanasekaran et al., 1995) , and in the McCune-Albright syndrome, which exhibits autonomous hyperproliferation in multiple endocrine glands (Weinstein et al., 1991) . Activating mutations have also been identi®ed for Ga i2 , referred to as the gip2 oncogene, in a subset of ovarian sex cord stromal tumors and adrenal cortical tumors (Lyons et al., 1990) . In addition, Ga 12 , referred as the gep oncogene (Xu et al., 1993 (Xu et al., , 1994 , was isolated as a transforming gene from a soft tissue sarcoma-derived cell (Chan et al., 1993) , although its role in tumorigenesis is still unclear. No naturally occurring activated mutations in members of the Ga q family have been described to date. Collectively, these observations implicate G protein a subunits and their linked cell surface receptors in hyperproliferative diseases, including cancer.
Mitogenic signaling through G protein-coupled receptors
Recent work has revealed that multiple intracellular signaling pathways mediate the proliferative eects of GPCRs. Initial studies addressing this issue had focused primarily on second messenger generating systems, such as adenylyl cyclases and phospolipases. However, although certain growth promoting agents such as LPA and thrombin activate G proteins of the G i family and thus inhibiting adenylyl cyclase, no direct correlation has been observed between induction of DNA-synthesis and decreased intracellular levels of cAMP. By contrast, many studies have implicated phospholipase C-b activation and enhanced phosphatidylinositol bisphosphate (PIP 2 ) hydrolysis in mitogenesis (Rozengurt, 1986) . However, experiments utilizing mutant tyrosine kinase receptors provided evidence that PIP 2 hydrolysis may be neither necessary nor sucient for mitogenesis (Coughlin et al., 1989; Mohammadi et al., 1992) . Consistent with those observations, a number of agonists acting on GPCRs, can eectively induce PIP 2 -hydrolysis, but fail to stimulate growth when added alone to quiescent cells (Moolenaar, 1991) . Although we cannot rule out that in certain cellular settings the persistent activation of the phospholipase C-PIP 2 hydrolysis pathway might elicit a mitogenic response and even lead to neoplastic conversion, the available body of information strongly suggests that additional eector pathways participate in the proliferative signaling by G protein-linked receptors. In this regard, recent work has revealed that the family of extracellular signal-regulated kinases, (ERKs) or MAP kinases, is a central component of the intracellular signaling pathway(s) controlling cell proliferation (see Marshall, 1995) . For example, the enzymatic activity of ERK1 and ERK2, p44
MAPK and p42 MAPK , respectively, referred herein as MAPKs, increases in response to mitogenic stimulation, and impeding their function prevents cell proliferation in response to a number of growth stimulating agents (Pages et al., 1993) . Moreover, constitutive activation of molecules upstream of the MAPK pathway is sucient for tumorigenesis (Mansour et al., 1994; Schlessinger, 1993) .
Growth factor receptors of the tyrosine kinase class activate MAPKs in a multistep process. For example, binding of EGF to its cognate receptors leads to the tyrosine phosphorylation, in the EGF receptor, of a docking site for the adaptor protein GRB2/SEM-5 (reviewed in Schlessinger, 1993) . This causes the recruitment of a guanine nucleotide exchange protein for Ras, SOS, to the plasma membrane, and the subsequent exchange of GDP for GTP-bound to Ras. GTP-bound Ras then proceeds to activate a cascade of protein kinases de®ned sequentially as MAP kinase kinase kinase, and represented by A-Raf, B-Raf, and Raf-1, and MAP kinase kinase such as MEK1 and MEK2. MEKs ultimately phosphorylate p44 MAPK and p42 MAPK , on both threonine and tyrosine residues, thereby increasing their enzymatic activity. In turn, MAPKs phosphorylate and regulate the activity of key enzymes and nuclear proteins, which ultimately regulate the expression of genes essential for proliferation (reviewed in Davis, 1993) . Although the mechanism of activation of MAPKs by GPCRs is still poorly understood, recent eorts from a number of laboratories is helping to elucidate how this family of cell surface receptors signal to MAPKs.
G protein-coupled receptors signal to the MAPK pathway
Activation of MAPKs in response to many agonists acting on GPCRs is well documented. For example, ligands as diverse as bombesin, endothelin-1, somatostatin, thromboxane A2, prostaglandin F2a, interleukin-8, platelet-activating factor (PAF), LHRH, TRH, formyl-methionyl peptide (fMLP), C5a peptide, sphingosine-1-phosphate, oxytocin, and angiotensin II, have been shown to eectively activate MAPKs upon stimulation of their cognate endogenously expressed receptors, in a variety of cell types (see van Biesen et al., 1996 for a recent review). Interestingly, many of these receptors were known to activate G proteins of the G i family, and were therefore sensitive to Ptx. In contrast, other receptors were known to couple to phospholipase-C PIP 2 hydrolysis by a Ptx-insensitive G protein, likely of the G q family (Moolenaar, 1991) . Thus, GPCRs could signal MAPK activation utilizing either G i or G q -dependent pathways. How these heterotrimeric G proteins then communicate to MAPK was unclear. For G q -coupled receptors, PKCdependent and independent pathways were reported, but expression of an activated mutant of Ga q did not enhance MAPK activity when stably expressed in NIH3T3 cells (our unpublished results) or transiently expressed in some cellular settings. For G i -coupled receptors, activation of MAPK was shown to be largely PKC-independent . In the latter case, activated forms of Ga i2 , the gip2 oncogene, was shown to induce MAPK activation when expressed in rodent ®broblasts (Gupta et al., 1992) . However, MAPK stimulation by gip2 was found to be Ptxinsensitive, suggesting an indirect mechanism of activation likely to result from secondary events involved in the acquisition of the transformed phenotype (Gupta et al., 1992) . Thus, the mechanism of activation of MAPK by receptors linked to G q or G i -related G proteins was largely unknown until recently.
A role for bg subunits of heterotrimeric G proteins linking G protein-coupled receptors to the Ras-MAPK pathway
To investigate the mechanism of MAPK activation by GPCRs, a number of laboratories have used the transient coexpression of an epitope-tagged form of MAPK together with GPCRs in readily transfectable cell lines, such as COS-7 cells. An advantage of this system is that several proteins can be simultaneously expressed at very high levels, without the in¯uence of biological changes that might be manifested during prolonged culturing of cells. Upon transfection into COS-7 cells, the epitope tagged MAPK could then be immunoprecipitated with an anti-epitope monoclonal antibody, and its enzymatic activity assayed using standard in vitro kinase assays (Crespo et al., 1994b; Pages et al., 1993) . In this cellular setting, it was observed that MAPK was potently activated upon ligand addition by either G q -coupled or G i -coupled receptors, respectively, in a Ptx-insensitive and -sensitive fashion (Crespo et al., 1994b; Faure et al., 1994; Koch et al., 1994) . However, under identical experimental conditions, activated forms of Ga i2 , Ga q , Ga s or Ga 12 did not induce any detectable increase in MAPK activity (Crespo et al., 1994b) .
Why the expression of activated Ga subunits failed to mimic receptor-mediated stimulation of MAPK is unclear. However, as discussed above, activated GPCRs act as guanine-nucleotide exchange factors for heterotrimeric G proteins, inducing the release of the Ga-bound-GDP and its replacement for GTP and the consequent dissociation of GTP-bound-Ga from bg complexes (Clapham and Neer, 1997) . Although it was initially thought that Ga subunits were the sole molecules responsible for signal transmission, it is now clear that both activated Ga and free bg subunits can stimulate a variety of eector pathways (Clapham and Neer, 1997) . That observation and the failure of mutationally activated Ga subunits to activate MAPK prompted the exploration of a role for bg heterodimers in signaling to the MAPK pathway. This led to the observation that membrane-bound forms of bg-subunits can directly activate biochemical routes leading to MAPK activation (Crespo et al., 1994b) , and stimulated the search for molecules acting downstream of G bg in this signaling pathway. Using a variety of experimental approaches, it was shown that stimulation of MAPK activity by coexpressed bg dimers required neither PLC-b nor PKC activation, but was blocked by molecules inhibiting Ras function (Crespo et al., 1994b; Koch et al., 1994) . Furthermore, bg subunits were later shown to be sucient to induce the accumulation of Ras in the GTP-bound, active form (Koch et al., 1994) . Taken together, these ®ndings indicate that signaling from GPCRs to MAPK involves bg heterodimers acting on a Ras-dependent pathway. This provided the ®rst indication that bg subunits link heterotrimeric G proteins to small G proteins of the Ras superfamily, and also established that the GPCR signaling pathway converges with that emerging from receptors of the tyrosine kinase class at the level of Ras.
Molecular mechanisms linking GPCRs and G bg to Ras
The elucidation of the molecular events linking GPCRs and G bg to the Ras-MAPK pathway has received extraordinary attention in the last few years. Perhaps the ®rst indication that tyrosine kinases might mediate the activation of MAPKs by GPCRs came from the observation that genistein, a relatively non-speci®c tyrosine kinase blocker, diminishes MAPK stimulation by LPA (Hordijk et al., 1994) . More recent studies demonstrated that activation of GPCRs in several cellular systems leads to the rapid phosphorylation of the adaptor protein Shc on tyrosine residues and the formation of Shc-GRB2 complexes (Chen et al., 1996; . Furthermore, Lutrell et al. (1996) have recently provided evidence that Src, or a Src-like kinase, mediates the bg induced phosphorylation of Shc, the recruitment of GRB2 and SOS, and the subsequent stimulation of the Ras-MAPK pathway. Extending these observations, recent studies have implicated other non-receptor tyrosine kinases in signaling from GPCR to MAPKs. These include several Src-like kinases such as Fyn, Lyn, Yes, and the more distantly related Syk (Ptasznik et al., 1995; Wan et al., 1996) , and a novel Ca 2+ and PKCdependent protein tyrosine kinase, Pyk2 (Della Dikic et al., 1996; Lev et al., 1995) . Interestingly, the latter is closely related to FAK (Focal Adhesion Kinase) which is involved in integrin signaling, and participates in the formation of focal complexes containing a number of molecules, including Src, paxillin, dynamin and Grb2. FAK was earlier shown to be activated by GPCRs (Gutkind and Robbins, 1992; Rankin et al., 1994) , and may represent an additional candidate mediating GPCR signaling to MAPK. Receptors of the tyrosine kinase class have been also shown to play a role in GPCR signaling. For example, PDGF and EGF receptors were found to become tyrosine-phosphorylated upon GPCR stimulation (Daub et al., 1996; Linseman et al., 1995) , and to participate in MAPK activation by GPCRs. We can conclude that a number of receptor and non-receptor tyrosine kinases might link GPCRs to the Ras-MAPK pathway. The relative contribution of each of these, or others yet to be discovered tyrosine kinases, in GPCR signaling to MAPK is likely to be cell type-speci®c, and is clearly a subject that warrants further investigation. Additional signaling molecules have been recently shown to connect GPCRs and G bg to the Ras-MAPK pathway. These include the protein tyrosine phosphatase SH-PTP1 (Gaits et al., 1996) , Ras-GRF (Mattingly and Macara, 1996) and PI3Kg (Lopez-Ilasaca et al., 1997). Ras-GRF is a distinct Ras guaninenucleotide exchange factor expressed in neuronal cells, and its activity was found to be enhanced in response to GPCR stimulation or upon coexpression of G bg by a still unclear mechanism (Mattingly and Macara, 1996) . In the case of PI3K, the observation that wortmannin, a phosphatidylinositol-3-kinase (PI3K) inhibitor, can diminish MAPK activation by GPCRs (see , provided the ®rst indication of a role for this lipid kinase in GPCR signaling to MAPK. Recently, a novel PI3K isoform that does not bind the p85 PI3K non-catalytic subunit was identi®ed and termed PI3Kg (Stoyanov et al., 1995) . This novel PI3K is not stimulated by tyrosine phosphorylation, but instead is activated upon direct physical interaction with G bg complexes (Stoyanov et al., 1995) . This PI3Kg was found to act downstream from G bg and upstream of Src-like kinases and Shc, Grb2, Sos and Ras, thus suggesting a potential mechanism whereby heterotrimeric G proteins can regulate non-receptor tyrosine kinases and, in turn, control the MAPK pathway (Lopez-Ilasaca et al., 1997) .
MAPK activation by GPCRs in a Ras-independent manner has also been reported based upon the inability to observe accumulation of Ras in the GTP-bound form in response to GPCR stimulation (Pace et al., 1995; Takahashi et al., 1997) . However, dominant interfering mutants for Ras prevented MAPK activation even in systems where GTP-bound Ras was not readily demonstrable (Pace et al., 1995) . Thus, it is possible that additional pathways might cooperate with limited amounts of GTP-bound Ras to stimulate MAPK, or that in certain cellular settings, GPCRs may stimulate MAPKs by yet to be identi®ed biochemical routes bypassing the requirement for Ras.
One such example may involve PKCs, as direct activation of PKCs by phorbol esters has been shown to induce MAPK by a mechanism that is still unclear. Although PKCs phosphorylate Raf (Heidecker et al., 1992; Kolch et al., 1993) , this does not result in increased Raf phosphorylating activity on its natural substrate, MEK (Macdonald et al., 1993) . In addition, PKC activation appears not to induce Ras-GTP accumulation in the vast majority of cell types (Bos, 1995) , however, it activates MAPK in a Ras-dependent manner in several cellular settings (Burgering and Bos, 1995; Hawes et al., 1995; Thomas et al., 1992b) . As Ras alone is not sucient to activate Raf fully in vitro (Macdonald et al., 1993) or when coexpressed in Sf9 cells (Williams and Roberts, 1994) , it is possible that PKCs might act on the MAPK pathway by facilitating the full activation of Raf upon binding to Ras (see Burgering and Bos, 1995) . Thus, PKC activation would then be expected to play a critical role on MAPK stimulation under conditions of submaximal activation of Ras by cell surface receptors. This might help explain some con¯icting observations regarding G qcoupled receptors, as these receptors can activate MAPK in a PKC-dependent , fully PKC-independent (Charlesworth and Rozengurt, 1997) , or partially PKC-dependent (Crespo et al., 1994a) manner. Thus, depending on the cellular system and the level of receptor expression, G qcoupled receptors would induce MAPK through a biochemical route including Ga q acting on phospholipase C and PKC, or initiated by Gq bg acting on a Rasdependent mechanism. At low receptor level or low concentration of agonist, the PKC component may play a critical role, as the limited availability of Gq bg might not be sucient to cause substantial Ras activation.
We can conclude that although additional molecules may participate in MAPK activation by GPCRs and G bg , many of the likely candidates may have already been identi®ed. Interestingly, several of the proteins described above exhibit a very restricted tissue distribution (Lev et al., 1995; Mattingly and Macara, 1996; Stoyanov et al., 1995) . Thus, the nature of the molecules linking GPCRs and G bg to MAPK stimulation is expected to depend on the repertoire of signaling molecules available in each particular cellular system.
Novel signaling pathways communicate GPCRs to the nucleus
GPCRs and tyrosine kinase receptors converge at the level of Ras to initiate the activity of a kinase cascade leading to MAPK activation and transcriptional regulation. Thus, stimulation of either type of receptor would be expected to elicit a similar response at the level of nuclear transcription factors. However, activation of GPCRs in NIH3T3 cells were found to induce a very distinct pattern of expression of immediate early genes of the jun and fos family (Coso et al., 1995a) . In particular, activation of m1 muscarinic receptors but not of PDGF receptors led to a remarkable expression of c-jun (Coso et al., 1995a) . Surprisingly, this response did not correlate with MAPK activation (Coso et al., 1995a) , thus suggesting that GPCRs control a distinct biochemical route regulating gene expression. In this regard, recent work demonstrated that the activity of the transcription factor c-jun is controlled by a novel family of enzymes structurally related but clearly distinct from MAPKs. These enzymes, named jun kinases (JNKs) (Derijard et al., 1994) or stress activated-protein kinases (SAPKs) (Kyriakis et al., 1994) , selectively phosphorylate the Nterminal transactivating domain of the c-jun protein thereby increasing its transcriptional activity. Interestingly, when JNK activity was investigated, it was observed that GPCRs, but not PDGF receptors, potently activated JNK in NIH3T3 cells (Coso et al., 1995a) , thus establishing that the GPCR signaling pathways diverge at the level of JNK from those utilized by certain tyrosine kinase receptors.
These ®ndings suggested that MAPKs but not JNKs were located downstream from Ras, as PDGF and other agonists known to activate the Ras pathway failed to stimulate JNK activity in a number of cellular settings (Coso et al., 1995a; Kyriakis et al., 1994) , and raised the possibility that proteins other than Ras may directly regulate biochemical pathways leading to the activation of JNK. In this regard, the Ras superfamily of GTPases comprises more than 50 members, which have been divided in six families based upon sequence similarity: Rab, Arf, Sar, Ran, Rho and Ras (see Hall, 1994) . The Rab, Arf and Sar groups have been shown to participate in the transport of proteins and vesicles among dierent intracellular compartments (Boguski and McCormick, 1993; Hall, 1994) . The Rho-family of GTP-binding proteins consists of the Rac, Rho and Cdc42 subfamilies, and have been shown to regulate several aspects of cytoskeleton functioning (Hall, 1994) . For example, the Rac subfamily includes Rac1 and Rac2, the former involved in membrane ruing (Hall, 1994) and the latter in NADPH oxidase-catalyzed superoxide formation in neutrophils. The Rho subfamily has at least 6 members, RhoA, RhoB, RhoC, Rho6, Rho7, and Rho8. RhoA has been shown to participate in the formation of actin-stress ®bers, as well as in mediating redistribution of cytoskeletal components (Hall, 1994) . The Cdc42 group consists of Cdc42Hs (referred here as Cdc42), G25K and RhoG (Hall, 1994) , and its function in mammalian cells is still largely unknown. Of interest, it had been reported that GTP-bound forms of the Rho-related proteins Rac1 and Cdc42 can speci®cally associate and activate a novel serine-threonine kinase, PAK (Manser et al., 1994) . This situation was highly analogous to that of the Ras-Raf interaction, thus suggesting that the Rho family of GTP binding proteins might also initiate activity of a kinase cascade (Manser et al., 1994) . This observation prompted several laboratories to examine whether the Rho family of GTPases participates in signaling to the JNK pathway.
Recently, it was found that the small GTP-binding proteins Rac1 and Cdc42 initiate an independent kinase cascade regulating JNK activity (Coso et al., 1995b) , and that Rac and Cdc42 are an integral part of the signaling route linking many cell surface receptors, including GPCRs, to JNK Minden et al., 1995) . Many novel components of this pathway have been recently identi®ed, and they include, sequentially, Pak and other members of the Ste20 family of serine-threonine kinase, members of the Ste11 family of kinases, including MEKK, and two members of the Ste7 class of kinases, including Sek/JNKK1/ MKK4 and MKK7 (Fanger et al., 1997; Tournier et al., 1997; Whitmarsh et al., 1997) . Detailed examination of the pathway linking GPCRs to JNK provided evidence that free bg dimers and, in some cellular systems, Ga 12 (Prasad et al., 1995) convey signals from this class of receptors to JNK. Furthermore, we and others have recently shown that JNK is potently activated by several naturally occurring human oncogenes (Coso et al., 1995b; Crespo et al., 1997; Minden et al., 1995; Whitehead et al., 1997) . However, whereas a function for JNK in apoptosis has been recently established (Goillot et al., 1997; Johnson et al., 1996; Xia et al., 1995) , the role for JNK in cellular transformation is still unclear.
Unsuspected role for G bg in signal transduction in mammalian cells ± The search for scaolding proteins Whereas the role of Ga subunits in signal transduction has been extensively studied, a newly available body of evidence suggests that in mammalian cells, bg subunits of heterotrimeric G proteins communicate GPCRs with the MAPK and JNK pathways acting, respectively, on a Ras and Rac1/Cdc42-dependent biochemical route. Thus, the emerging picture is that bg heterodimers provide a molecular bridge between heterotrimeric G proteins and small GTP-binding proteins. Although this may represent a novel concept in signal transduction, its similarity with the pathway linking G proteincoupled pheromone receptors to MAPK-like proteins in the budding yeast S. cereviseae is striking, and suggests that the G bg connection to small GTPases represents a biologically relevant example of a pathway extraordinarily conserved throughout evolution. In S. cereviseae, extracellular ligands (a or a factors) activate cell surface pheromone receptors which, in turn, induce the dissociation of a heterotrimeric G protein into a (GPA1) and bg (Ste4, Ste18) subunits (see Herskowitz, 1995) . Free bg dimers then activate a serine-threonine kinase, Ste20, stimulating the activity of a linear cascade of kinases including sequentially Ste11 and Ste7, which phosphorylate and activate the yeast MAPK homolog Fus3 and Kss1. Extensive search for molecules linking yeast bg complexes to Ste20 has led to the recent discovery that Cdc42 participates in Ste20 activation (Simon et al., 1995) and that Ste4 might directly bind and activate Cdc24, a nucleotide exchange factor for Cdc42 (Zhao et al., 1995) . Thus, in yeast, the G protein b subunit can initiate activity of a MAPK cascade by binding an exchange factor for the Cdc42 GTPase, and then this GTP-binding protein physically interacts with the most upstream kinase, Ste20, causing its activation (Herskowitz, 1995) . Available data suggest that additional molecules might be also involved, including a protein designated Ste5, which binds yeast bg and plays a role as a platform or scaold recruiting Ste11, Ste7, Kss1/Fus3 (Akada et al., 1996; Whiteway et al., 1995) .
In mammalian cells a more complex array of signaling molecules appears to connect GPCRs and G bg to parallel MAPK cascades. These include lipid kinases, non-receptor and receptor tyrosine kinases, SH2 and SH3-containing adapter molecules, proteinphosphatases, PKCs, and Ras-GRF. However, we can not exclude the possibility that G proteins may directly regulate the activity of unidenti®ed guanine-nucleotide exchange factors, as observed in yeast. Although no mammalian homolog for Ste5 has been so far described, a recent report indicates that a PDZcontaining protein termed InaD acts as a scaold linking Ga q to several molecular components of the visual system of the fruit¯y (Tsunoda et al., 1997) . A mammalian InaD homolog has been recently described (Philipp and Flockerzi, 1997) , and several putative PDZ-containing adaptor can be found in the GeneBank (unpublished observation). Based upon these recent ®ndings and the critical role of Ste5 in signal transduction in yeast, we can postulate that still unknown scaolding proteins may also participate in the mammalian pathways connecting heterotrimeric G proteins to MAPK cascades.
Additional pathways connect G proteins to the nucleus: Rho links GPCRs to the serum response element and to cellular transformation As described above, activation of GPCRs and tyrosine kinase receptors induces a distinct pattern of expression of early response genes of the c-jun and c-fos family. However, these two classes of receptors elicited a similar response on c-fos expression (Coso et al., 1995a) . The induction of c-fos transcription is mediated by several promoter elements . Among these, the Serum Response Element (SRE) is believed to play a central regulatory (Treisman, 1994 (Treisman, , 1995 , as this sequence has been shown to be necessary and sucient for the rapid induction of c-fos by most growth-promoting stimuli (Greenberg et al., 1987; Johansen and Prywes, 1994) . A number of proteins that bind the c-fos SRE can mediate SRE-dependent transcription (Treisman, 1994 (Treisman, , 1995 , including a transcription factor of 67 kD, termed Serum Response Factor (SRF), that binds the SRE in vivo and in vitro as a dimer (Treisman, 1994 (Treisman, , 1995 . Another protein forms a ternary complex with SRE and the SRF dimer and has been therefore termed Ternary Complex Factor or p62 TCF (Treisman, 1995) . TCF can be phosphorylated by both MAPK and JNK (Cavigelli et al., 1995; Gille et al., 1995; Whitmarsh et al., 1997) , thus providing a mechanism whereby SRE activity can be regulated in response to the activation of the Ras-MAPK and Rac1/Cdc42 JNK signaling pathways. Interestingly, SRE can also be regulated in a TCF-independent manner, and certain TCF-independent signaling pathways acting on SRE have been shown to be controlled by the small GTP-binding protein Rho . Regarding the latter, evidence presented by suggests that Rho signals to the SRE through a novel pathway independent of any MAPKs described to date. Furthermore, recent work established that GPCRs can signal through this novel TCFindependent pathway , and that RhoA or other Rho-related proteins act as integral components of this biochemical route connecting GPCRs, likely through G bg and Ga 12 , to both transcriptional activation of the SRE and neoplastic transformation .
Network of GTPases
Another interesting area for investigation involves the interrelationship among small GTPases. Microinjection studies suggest that Cdc42, Rac and RhoA can be considered, sequentially, as part of a`small GTPbinding protein cascade' (Nobes and Hall, 1995a,b) . However, the mechanism by which one small G protein activates the subsequent one is yet unknown. Another interesting ®nding is that although activation of JNK by G protein-linked and tyrosine kinase receptors is initiated by Rac1/Cdc42, the dominant negative mutant of Ras can also block JNK-stimulation by these receptors (Coso et al., 1995b) , further supporting a functional relationship among these GTPases. In this regard, evidence for a regulatory role for a Ras-like protein on the activation of another, Cdc42, has already been obtained in the yeast pheromone pathway. In this case, the Ras homolog Rsr1 appears to play an important regulatory role by binding Cdc24 and, probably, by positioning this guanine nucleotide exchange factor within the cell, thus allowing its interaction with Cdc42 and its targets (Zheng et al., 1995) . These observations represent the ®rst example of convergence between Ras-like (Rsr1) and Rho-like (Cdc42) biochemical routes, and might help explain the regulatory eect of Ras on Rac/Cdc42 in mammalian cells. Conversely, Rho-like proteins might also regulate Ras exchange factors, Sos and Ras-GRF, upon interaction with their DH domains, a possibility that has not yet been fully explored.
Regulation of kinase cascades by second-messenger generating systems
Novel signaling eects for elevated intracellular [Ca 2+ ] have been recently reported. These include the ability to enhance the guanine-nucleotide exchange activity of Ras-GRF through a conserved domain termed`IQ' (Buchsbaum et al., 1996; Farnsworth et al., 1995; Freshney et al., 1997) ; to activate a novel tyrosine kinase, Pyk2, implicated in GPCR signaling to JNK and MAPK in certain cells Dikic et al., 1996; Lev et al., 1995; Tokiwa et al., 1996) ; to activate a novel calcium-calmodulin-dependent P13K activity (Joyal et al., 1997) ; and to activate the dephosphorylation of nuclear transcription factors through the calmodulin-dependent phosphatase, calcineurin (Chow et al., 1997; Sugimoto et al., 1997) . Thus, it is becoming increasingly clear that limited changes in intracellular [Ca 2+ ], caused by many G protein-linked and tyrosine kinase receptors, might exert a profound eect on many aspects of signal transmission.
Another classical second messenger that can in¯uence signal transmission is cAMP. In many cell types, increased levels of cAMP will lead to a PKAdependent inhibition of MAPK stimulation (Burgering et al., 1993; Iyengar, 1994, 1995) . The precise target for PKA is still unclear, but current evidence suggests that PKA phosphorylates Raf thus preventing its activation by Ras (see Burgering and Bos, 1995) , and that PKA activates certain inhibitory molecules, such as the small GTP-binding protein Rap1 (Altschuler et al., 1995) . Surprisingly, however, in some cells, including PC12 and Swiss 3T3 cells, cAMP elevating agents induce MAPK activation Faure et al., 1994; Vossler et al., 1997) , and a recent report has suggested that the latter involves Rap1b acting on B-Raf (Vossler et al., 1997) . Interestingly, several adenylyl cyclases have been identi®ed and shown to be regulated by Ga s , Ga i , G bg , Ca 2+ or PKC in a subtype-speci®c manner (Sunahara et al., 1996; Taussig and Gilman, 1995) . These ®ndings suggest that many cell surface receptors will activate adenylyl cyclases thus initiating a complex series of regulatory events on MAPK cascades, an area that is still largely unexplored.
Receptor and pathway cross-talk
Recent studies have revealed that activation of angiotensin receptors in smooth muscle cells causes the activation of tyrosine kinase receptors for PDGF (Diverse-Pierluissi et al., 1997; Du et al., 1996) , and stimulation of LPA receptors leads to the tyrosine phosphorylation of EGF receptors in Cos-7 (Daub et al., 1996) and HEK 293 cells , the latter resulting from the activation of Src-like kinases by GPCRs . While the biological signi®cance of cross-talk between GPCRs and tyrosine kinase receptors is still unclear, at the biochemical level tyrosine phosphorylated receptors might provide a docking site for the formation of multiprotein signal transducing complexes. Similarly, GPCR stimulation lead to the activation of FAK (Gutkind and Robbins, 1992) , a component of the integrin-signaling pathway (Hanks and Polte, 1997; Schlaepfer and Hunter, 1996) . Thus, biological events triggered by GPCRs might involve the lateral dissemination of the signal, thus engaging the functioning of other cell surface receptors.
Another emerging theme is the ability of one kinase cascade to in¯uence the biochemical or biological outcome of another. For example, recent work has established that the balance between JNK and MAPK activation can determine whether cells will undergo programmed cell death or survive (Cuvillier et al., 1996; Xia et al., 1995) . In addition, Cobb and coworkers have recently shown that activation of Rac1-Pak can synergize the submaximal stimulation of the MAPK pathway, probably by direct phosphorylation of MEK, resulting in enhanced ability to be activated by Raf (Frost et al., 1997) . The implication of this study is that proteins at the level of MEK (MEK1, MEK2, MKK3, MKK4/SEK/JNKK1, MEK5, MKK6, MKK7) may be susceptible to regulation by components of other kinase cascades, an exciting prediction that warrants further investigation.
Signal integration in the nucleus
Perhaps the most obvious and yet poorly understood site for signal integration lies in the nucleus. Regulation of transcriptional activity by phosphorylation of transcription factors appears now to be the norm rather than the exception. These events can cause increased activity of transcription factors by enhancing their binding to co-activators, increasing their protein stability, aecting their ability to dimerize with other transcription factors, or causing their dissociation from transcriptional repressors Karin and Hunter, 1995; Su and Karin, 1996; Treisman, 1996) . However, phosphorylation of transcription factors can also cause a dramatic decrease in the ability to bind DNA, hence inhibiting their functional activity . In the last few years we have witnessed an explosion in the number of potential transcription-factor kinases (Davis, 1995; Goedert et al., 1997) , and we are only just beginning to understand how the interplay among these kinases and positive and negative modulatory events control transcriptional activity.
Another area that is currently being revisited is the complexity of regulatory elements found in the promoter region of growth-regulating genes. For example, the idea that JNK activation by cell surface receptors leads to c-jun expression through an AP1 site in the c-jun promoter has been recently challenged . Unexpectedly, it was observed that a critical regulatory element in the c-jun promoter binds members of the MEF2 family of transcription factors , and one such MEF2 protein, MEF2C, was recently found to be regulated by the p38 MAPK (Han et al., 1997) . Thus, information currently available suggests that expression of c-jun may be under the control of p38-related pathways. Consistent with this hypothesis, stimulation of cells derived from JNK3 knock out animals, did not result in either detectable activation of JNK nor phosphorylation of c-Jun . Nevertheless, enhanced expression of c-jun messages in response to excitatory stimuli was similar to that of control cells . Thus, the c-jun promoter may be the site of convergence of several kinase cascades. Similarly, as described above, the c-fos promoter contains an SRE that can be regulated by both MAPK and JNK acting on the TCF, and by a yet to be identi®ed pathway, initiated by Rho, aecting SRF function . However, the c-fos promoter also contains CRE, SIE, Spl and other sites adjacent to the SRE Johansen and Prywes, 1994; Runkel et al., 1991) , suggesting that the regulation of the c-fos promoter may depend on the multiple positive and negative interactions likely to occur among their corresponding binding proteins. Thus, whereas the regulation of transcription from isolated SRE sequences has received renewed attention, how coincident incoming signals are integrated at the level of the c-fos promoter to regulate c-fos expression is still largely unknown. In summary, the emerging picture is that transcriptional activation or repression most likely results from the activity of a number of interlinked regulatory molecules and pathways, rather than from a linear series of signaling events.
From signal transduction to signal integration
The simplest model of how GPCRs and other cell surface receptors communicate to the nucleus and control gene expression, involves the activation of small GTP-binding proteins of the Ras superfamily which, in turn, control the activity of parallel kinase cascades resulting in the phosphorylation of critical nuclear transcription factors. However, activation of GPCRs leads to a number of signaling events that, although dissectable for their examination under controlled experimental conditions, do not occur in isolation in their natural settings. As outlined above, upon GPCR activation, both G a and G bg stimulate biochemical routes leading to the concomitant activation of several small GTP-binding proteins of the Rassuperfamily, a variety of second messenger generating systems, and even other cell surface receptors, such as PDGF and EGF receptors. These, in turn, stimulate a number of highly interconnected cytoplasmic signaling pathways that lead to a temporally distinct pattern of activation of members of the MAPK superfamily, including many recently identi®ed Lawler et al., 1997) . Ultimately, these kinases will reach the nucleus and thus control gene expression by changing the status of phosphorylation of nuclear proteins, including transcription factors, and thereby aecting an intrincated balance of nuclear regulatory molecules. Therefore, the ®nal biological outcome, including cell proliferation, most likely results from a network of responses, rather than from a single series of sequential events. Recent advances in our understanding of basic mechanisms that regulate signal transduction, will now aord the opportunity to unravel the intricacies of how these signals are integrated to elicit biological responses, and how perturbation of this signaling network can result in cancer. Furthermore, it will also provide unique opportunities to identify previously unsuspected molecular targets for pharmacological intervention in this disease.
